Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant

Table 3 Multivariate logistic regression analysis of risk factors for CAPA

Variables		P	OR	95% CI
Variables in equation	Immunocompromised status	0.023	2.220	1.116 ~ 4.414
	CRP ≥ 50 mg/L	0.004	2.182	1.279 ~ 3.721
	NLR ≥ 5.7	0.043	1.726	1.017 ~ 2.930
	Number of antibiotics ≥ 3	< 0.001	3.926	2.243 ~ 6.869
Variables not in equation	Age	0.751
	Sex	0.648
	Diabetes	0.565
	Chronic obstructive pulmonary disease	0.139
	Tocilizumab	0.285
	Cumulative glucocorticoid dose* ≥1500 mg	0.077

Bold values represent p < 0.05, indicating statistical significance
Abbreviations: CAPA, COVID-19-associated pulmonary aspergillosis; CRP, C-reactive protein; NLR, neutrophil-lymphocyte ratio; OR, odds ratio; CI, confidence interval; *Hydrocortisone dose was taken as reference

ISSN: 1471-2334